BioAssay Works is excited to announce our participation at ADLM 2026 Clinical Lab Expo, taking place July 28-30 in Anaheim! Visit us at Booth #2069.

For over two decades, BioAssay Works has developed and manufactured qualitative and quantitative lateral flow assays (LFAs) across healthcare, veterinary, environmental, and food testing applications. This year, we’re spotlighting a specialty area where our platform has become mission-critical: biotherapeutic identity testing for biopharmaceutical manufacturers.

As the number of biologics in development multiplies and manufacturing portfolios grow more complex, lot-release identity testing under 21 CFR § 610.14 has become an increasingly demanding specificity challenge. We’ll be at the booth to discuss how our LFA-based identity kits help manufacturing teams confidently distinguish structurally similar biologics — including emerging formats like ADCs — at the point of production.

Explore the topic in depth in our recent article:

• Biotherapeutic Identity Testing: From Novel Concept to Mission-Critical Manufacturing Requirement

We invite you to schedule a meeting at our exhibit booth to discuss how BioAssay Works can support your diagnostic innovation — whether in identity testing or across our full range of LFA development services.

See you in Anaheim!